Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
August 2014

Long-Acting Injectable Antipsychotics
The choice of whether or not to prescribe a long-acting injectable antipsychotic and, if so, which one to choose, should be based on the patient's ability to adhere to a oral medication regimen, individualized estimated risks and benefits, and cost.

Antidepressants and Suicidal Behavior: Effects of Dose and Age
For patients prescribed antidepressants, initiating treatment with higher doses may increase the risk of suicidal ideation and behavior in younger but not older patients.

In Brief
Girls with Anorexia Nervosa Have Increased Risk of Fractures; PTSD and Use of Antidepressants and Benzodiazepines during Pregnancy Increase Risk of Preterm Birth

Ramelteon (Rozerem)
Ramelteon (Rozerem) shows benefit for adults with insomnia in some trials, but the studies have been mostly short-term and the magnitude of difference compared with placebo has been small.

About the BTP Newsletter

Our subscribers say BTP is…

"Very relevant, practical, and thought-provoking."

"About the only thing left without drug ads...objective and balanced."

"Succinct, readable, clear, timely and relevant!"

"Well written and scientifically sound."

Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.

From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.

Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.

We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.